| Current Price | $1.64 | Mkt Cap | $117.4M |
|---|---|---|---|
| Open | $1.66 | P/E Ratio | 135.54 |
| Prev. Close | $1.64 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.63 - $1.67 | Volume | 1 |
| 52-Wk Range | $1.00 - $3.55 | Avg. Daily Vol. | 755,011 |
A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.
| Current Price | $1.64 | Mkt Cap | $117.4M |
|---|---|---|---|
| Open | $1.66 | P/E Ratio | 135.54 |
| Prev. Close | $1.64 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.63 - $1.67 | Volume | 1 |
| 52-Wk Range | $1.00 - $3.55 | Avg. Daily Vol. | 755,011 |
The best Bull and Bear pitches based on recency and number of recommendations.
It is outperforming the market. Volume low. Nobody is panicking.
Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.
Read the most recent pitches from players about PLX.
Recs
Paul8888888
(< 20)
Submitted: 1/23/2016 2:31:12 PM :
Start Price:
$0.86
NYSE MKT:PLX Score:
-35.33
It is outperforming the market. Volume low. Nobody is panicking.
Recs
SqwiiTrader
(< 20)
Submitted: 11/5/2013 2:56:24 PM :
Start Price:
$4.40
NYSE MKT:PLX Score:
-203.91
IHS pattern
Recs
TMFBiologyFool
(68.78)
Submitted: 5/2/2012 12:24:24 PM :
Start Price:
$7.02
NYSE MKT:PLX Score:
+280.32
Low patient numbers + 2 competitors = tough launch.
I actually like the manufacturing technology, but next drug is still years away.
Find the members with the highest scoring picks in PLX.
midastouch017 (< 20) Score: +734.62
For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| 1or5stars | 98.32 | 2/10/2009 |
|
3W | $2.66 | -38.35% | +402.36% | +440.71 | 0 Comment | |
| anticitradeshort | 28.16 | 4/20/2009 |
|
NS | $2.27 | -27.75% | +403.06% | +430.81 | 0 Comment | |
| Spelunkin | 26.51 | 11/3/2009 |
|
5Y | $10.39 | -84.22% | +310.53% | +394.74 | 0 Comment | |
| anticitrademix2 | < 20 | 11/2/2009 |
|
5Y | $9.90 | -83.43% | +308.99% | +392.42 | 0 Comment | |
| anticitrademix | < 20 | 11/2/2009 |
|
5Y | $9.90 | -83.43% | +308.99% | +392.42 | 0 Comment | |
| MSFOBV1YH | 96.36 | 11/4/2009 |
|
5Y | $10.93 | -85.00% | +303.64% | +388.63 | 0 Comment | |
| ModernDayWarrior | 32.35 | 10/29/2009 |
|
5Y | $9.58 | -82.88% | +304.87% | +387.75 | 0 Comment | |
| TrackDuality | < 20 | 11/6/2009 |
|
5Y | $11.89 | -86.21% | +300.79% | +387.00 | 0 Comment | |
| mathieugp | 44.17 | 9/28/2009 |
|
3M | $7.87 | -79.16% | +306.18% | +385.34 | 0 Comment | |
| 39272x4 | 22.31 | 11/9/2009 |
|
5Y | $12.00 | -86.33% | +294.52% | +380.85 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
